''On consolidated basis
Quarter ended December 2024 compared with Quarter ended December 2023.
Net sales (including other operating income) of Dr Lal Pathlabs has increased 10.73% to Rs 596.7 crore. Operating profit margin has declined from 26.09% to 25.81%, leading to 9.53% rise in operating profit to Rs 154.00 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 19.86% to 19.61%. Employee cost increased from 20.23% to 21.18%. Other expenses fell from 33.83% to 33.40%. Selling and administration expenses rose from 14.42% to 14.53%.
Other income rose 37.16% to Rs 25.1 crore. PBIDT rose 12.71% to Rs 179.1 crore. Provision for interest fell 24.29% to Rs 5.3 crore.
PBDT rose 14.42% to Rs 173.8 crore. Provision for depreciation fell 1.39% to Rs 35.5 crore.
Profit before tax grew 19.33...
Pleaselogin & subscribe to view the full report.
More Reports
|
|